http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005027970-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2004-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2005027970-A1 |
| titleOfInvention | Drugs for cancer treatment |
| abstract | The present invention relates to a medicament for treating cancer, which uses a substance that inhibits the activities of insulin-like growth factor-I (IGF-I) and insulin-like growth factor-II (IGF-II) to synergistically increase the effect of treating cancer. It is an issue to provide. According to the present invention, a medicament for treating cancer comprising a substance that inhibits the activities of IGF-I and IGF-II and administered in combination with radiation; a substance that inhibits the activities of IGF-I and IGF-II A pharmaceutical for cancer treatment comprising a combination of a substance having antitumor activity is provided. |
| priorityDate | 2003-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 756.